The nuclear expression of poly (ADP-ribose) polymerase-1 (PARP1) in invasive primary breast tumors is associated with chemotherapy sensitivity
Authors:
- 1 February 2015
- journal article
- research article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 211 (2) , 130-137
Abstract
No abstract availableKeywords
Funding Information
- National Basic Research Program of China (2009CB521700)
- China Postdoctoral Science Foundation (20110490788)
- Specialized Research Fund for the Doctoral Program of Higher Education (20131202120002)
- Tianjin Research Program of Application Foundation and Advanced Technology (14JCQNJC09800)
- Program of Chinese National Natural Science Foundation (81172531, 81202101, 31400673)
- Program for Chang Jiang Scholars and Innovative Research Team in University of Ministry of Education of China (IRT0743)
- Innovation Funding for graduate of Tianjin Medical University, third phase of the 211 Project for Higher Education (2010GSI17)
This publication has 36 references indexed in Scilit:
- Gene Modules and Response to Neoadjuvant Chemotherapy in Breast Cancer Subtypes: A Pooled AnalysisJournal of Clinical Oncology, 2012
- Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast CancerNew England Journal of Medicine, 2011
- Gene Pathways Associated With Prognosis and Chemotherapy Sensitivity in Molecular Subtypes of Breast CancerJNCI: Journal of the National Cancer Institute, 2010
- Upregulation of Poly (ADP-Ribose) Polymerase-1 (PARP1) in Triple-Negative Breast Cancer and Other Primary Human Tumor TypesGenes & Cancer, 2010
- PARP inhibitors and the treatment of breast cancer: beyond BRCA1/2?Breast Cancer Research, 2009
- Poly(ADP-ribose) polymerase-1 polymorphisms, expression and activity in selected human tumour cell linesBritish Journal of Cancer, 2009
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast CancerJNCI: Journal of the National Cancer Institute, 2009
- Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27Journal of Clinical Oncology, 2008
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991
- Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapyCancer, 1988